SCOPUS BIOPHARMA INC (SCPS) Stock Earnings & Estimates
USA - NASDAQ:SCPS - US8091711015 - Common Stock
0.1682 USD
-0.17 (-50.54%)
0.12 USD
-0.05 (-28.66%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | ||||||
| EBITDA YoY % growth | N/A | N/A | -2.69M | -10.13M -276.58% | -19.533M -92.82% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -260K | -690K -165.38% | -2.69M -289.86% | -10.13M -276.58% | -19.535M -92.84% | N/A | N/A | N/A | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A -55.81% | N/A 8.21% | N/A -49.59% | N/A 22.25% | N/A 20.69% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2021 Q2Q % growth | -0.08 | -0.23 | 0.15 | 65.90% |
| Q2 2021 Q2Q % growth | -0.97 | -0.23 | -0.74 | -313.47% |
| Q1 2021 Q2Q % growth | -0.22 | -0.08 | -0.14 | -169.61% |
| Q4 2020 Q2Q % growth | -0.06 | -0.09 | 0.03 | 34.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | N/A |
| Revenue | N/A | N/A | N/A | N/A |